The U.S. Department of Justice has announced a case involving one of the largest coordinated health care fraud enforcement actions in the department's history. Charging 455 defendants in connection with schemes involving more than $6.5 billion in alleged false claims submitted to Medicare, Medicaid, TRICARE, and private health insurers.

The nationwide operation, known as the 2026 National Health Care Fraud Takedown, involved federal and state investigators working across fifty-seven federal districts in forty-one states and territories. According to the Justice Department, the defendants include approximately ninety physicians and other licensed medical professionals, making it one of the broadest crackdowns ever directed at health care fraud.

The scope of the operation demonstrates how widespread health care fraud has become. While most media attention tends to focus on individual recipients, the majority of health care fraud is perpetrated by practitioners. Cases announced as part of the takedown stretched from California and Texas to Florida, New York, Connecticut, Puerto Rico, Hawaii, and numerous other jurisdictions…

2026 has been the year of the energy shock. But while the world fixated on oil, another strategic resource staged one of the sharpest rallies in commodities: lithium.

Battery grade lithium carbonate has roughly doubled over the past year, to around $20,000 a ton, near three year highs, as supply tightened and demand from EVs, grid storage, and AI data centers surged. Morgan Stanley now forecasts a global lithium deficit in 2026.

EnergyX is positioned right in the middle of it. Its Project Lonestar™ demonstration plant in Texas is now producing battery grade lithium, one of the largest direct lithium extraction facilities in the United States. At full commercial scale, the company projects up to 50,000 tons a year and roughly $1 billion in annual revenue at current market prices.*

Backed by GM, POSCO, Eni, and the DOE. 50,000+ investors. $180M+ raised. Shares are $13 before the July 16 deadline.*

Federal prosecutors simultaneously announced criminal charges and civil settlements involving hospitals, physicians, pharmacies, behavioral health providers, durable medical equipment suppliers, telehealth companies, laboratories, and substance abuse treatment facilities.

According to the Department of Justice, because government programs like Medicare and Medicaid spend billions of dollars annually providing medical care to tens of millions of Americans, they are attractive targets for organized criminal networks and unscrupulous providers. Because practitioners have been using the systems for years, they know how those systems work and can exploit their insider knowledge for personal gain. 

The notion that individual recipients, such as undocumented immigrants, are responsible for most health care fraud is a myth. Providers, all of whom are U.S. citizens, utilizing fraudulent billing practices not only waste taxpayer money but also expose patients to unnecessary medical procedures, delay legitimate care, contribute to higher insurance premiums, while undermining public confidence in the health care system. In several cases announced this year, prosecutors alleged that fraudulent practices caused significant patient harm and, in some instances, contributed to patient deaths.

According to the Wall Street Journal, the largest alleged schemes were billion-dollar fraud operations involving unnecessary wound care products and medical equipment. In one case, prosecutors accused health care executives of orchestrating more than $1 billion in fraudulent Medicare claims through networks of companies and illegal kickback arrangements. Another common fraud practice involved billing the government for treatments that never occurred or for patients who didn’t exist.  

New analytical techniques using artificial intelligence (AI) helped officials in the Department of Justice identify and track patterns of suspicious activity across Medicare and Medicaid. While AI has helped scammers and fraudsters carry out more illicit activities, it can also help law enforcement agencies spot and locate larger patterns of fraud.

Health care fraud is among the largest and most pervasive types of organized criminal activity in the United States, and an aging population requiring more medical care will only increase opportunities for fraudsters in the coming years.

*Disclaimer: Energy Exploration Technologies, Inc. (“we”, “us”, “our”, and “EnergyX” is conducting an offering of securities pursuant to Regulation A of the Securities Act of 1933, as amended. An offering statement covering this offering has been qualified by the U.S. Securities and Exchange Commission (the “SEC”). Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. Offers and sales of the securities are being made solely by means of the qualified offering circular. Investing in our securities involves significant risks. Before investing, you should consult with your financial advisor, accountant, and/or attorney legal, and carefully review the qualified offering circular (including the “Risk Factors” section) and any offering circular supplements.

The most recent qualified offering circular is available at https://www.sec.gov/Archives/edgar/data/1830166/000149315226017123/form253g2.htm. The most recent qualified offering circular and any supplements can also be found on the SEC’s EDGAR filing database, available at www.sec.gov/edgar/search/. Prospective investors should note that neither the SEC nor any federal or state securities commission or regulatory authority has approved or recommended our securities or determined that our offering circular is truthful or complete. Any representation to the contrary is unlawful. We are not a broker-dealer or investment adviser registered under the Securities Exchange Act of 1934 or the Investment Advisers Act of 1940. No communication made by us or any of our affiliates, through this communication or any other medium, should be construed as a recommendation to purchase, sell, or hold any securities, or as investment, tax, financial, accounting, legal, regulatory, or compliance advice. Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. The content presented here is provided for general information purposes only and is not intended to solicit the purchase of securities or to be used as investment, legal or tax advice. Statement Regarding Forward-Looking Statements The information presented herein may include forward-looking statements, estimates, or projections regarding our anticipated future performance. If present, these statements are subject to risks, uncertainties, and assumptions. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “future” or “continue”, the negative of these terms, and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections, if any, are based upon various assumptions made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of any such forward-looking statements, estimates or projections. Our actual performance may be materially different from any such statements, estimates or projections. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations.